Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries
出版年份 2016 全文链接
标题
Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume 139, Issue 12, Pages 2771-2780
出版商
Wiley
发表日期
2016-08-20
DOI
10.1002/ijc.30392
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand
- (2016) Jie-Bin Lew et al. PLoS One
- US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines
- (2015) Mona Saraiya et al. JNCI-Journal of the National Cancer Institute
- US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines
- (2015) Mona Saraiya et al. JNCI-Journal of the National Cancer Institute
- HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis
- (2014) L Rodríguez-Carunchio et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon
- (2014) Archana Chatterjee Expert Review of Vaccines
- The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds
- (2014) Henry C Kitchener et al. HEALTH TECHNOLOGY ASSESSMENT
- Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study
- (2014) Sepehr N Tabrizi et al. LANCET INFECTIOUS DISEASES
- The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England
- (2013) Leonardo Simonella et al. CANCER CAUSES & CONTROL
- Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine
- (2013) Mélanie Drolet et al. INTERNATIONAL JOURNAL OF CANCER
- Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010
- (2013) Lauri E. Markowitz et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical Human Papillomavirus Detection Forecasts Cervical Cancer Risk in Women Over 18 Years of Follow-Up
- (2012) Philip E. Castle et al. JOURNAL OF CLINICAL ONCOLOGY
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
- (2012) Debbie Saslow et al. Journal of Lower Genital Tract Disease
- Modeling Preventative Strategies against Human Papillomavirus-Related Disease in Developed Countries
- (2012) Karen Canfell et al. VACCINE
- Impact of vaccine protection against multiple HPV types on the cost-effectiveness of cervical screening
- (2012) Veerle M.H. Coupé et al. VACCINE
- Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study
- (2012) R. Legood et al. BMJ-British Medical Journal
- Pilot study will assess whether HPV test should replace smears to screen for cervical cancer
- (2012) J. Wise BMJ-British Medical Journal
- Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
- (2012) Beatriz Serrano et al. Infectious Agents and Cancer
- Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years
- (2010) Prudence Creighton et al. BMC PUBLIC HEALTH
- The Expected Impact of HPV Vaccination on the Accuracy of Cervical Cancer Screening: The Need for a Paradigm Change
- (2009) Eduardo L. Franco et al. ARCHIVES OF MEDICAL RESEARCH
- Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine
- (2009) Suzanne M. Garland et al. JOURNAL OF INFECTIOUS DISEASES
- Risk Assessment to Guide the Prevention of Cervical Cancer
- (2009) Philip E. Castle et al. Journal of Lower Genital Tract Disease
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now